nygazet.com logo
Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests
business

Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests

1 min read

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

Better injections and better pills. It's official: Eli Lilly appears to be beating Novo Nordisk at the weight loss game. On Thursday, Lilly announced that its forthcoming GLP-1 pill, called orforglipron, bested Novo Nordisk's existing oral semaglutid... [4647 chars]

Read Original Article

Source: Business Insider

Visit Source

Share this article